General | 04 November 2026
Evonik’s third-quarter profit jumps 40%
Specialty chemicals giant expects full-year earnings to land in the upper half of its guidance range
Specialty chemicals giant expects full-year earnings to land in the upper half of its guidance range
Despite the margin pressure, Clariant maintained its full-year 2026 guidance, backed by a strong order book, particularly in Catalysts
NIPPON CERAMO brings internationally proven coating technology to Indian shipyards as the country’s shipbuilding industry
The cloud-based application gives users access to a digital database of colour formulas through desktop computers, tablets and mobile device
GOO Chemical specializes in high-performance materials used in electronic components and chip production
Röchling Industrial to transition to Celanese POM ECO-C materials based on Carbon Capture and Utilization (CCU) feedstock
In Q3, the company delivered operating cash flow of $538 million and free cash flow of $461 million.
Advantaged investments, technology, and $16.9 billion in structural cost savings since 2019 are expanding our earnings power
The global agricultural leader registered group sales of $17.3 billion for the first nine months of the year
The numbers underline the company's ability to sustain profitable growth despite challenging global headwinds
Neogen, however, continued to face cost pressures arising from the Dahej plant rebuild, tolling arrangements, capital expenditure at NIL and elevated input costs
Epigral is accelerating its capacity expansion programme, with its CPVC and ECH projects entering their final stages and trial runs already underway
The most notable highlight of the quarter was the PAT which skyrocketed by an extraordinary 1,259%
The company's operating revenue, however, surged 40.9% year-on-year to Rs 2,773 crore in Q2 FY27
Revenue from operations, however, surged 116.51% year-on-year to Rs 272.88 crore
Petrokens provides detailed engineering services to several industrial sectors, including energy, chemicals and industrial infrastructure
The company reported a consolidated revenue of Rs 346.7 crore in Q2 FY27
The next product planned for commercialization is N-Methyl Morpholine
Board approves Rs. 70 crore CapEx plan
Consolidated revenue from operations jump 104.9% year-on-year to Rs.934.37 crore
Subscribe to our newsletter & stay updated.
